AlphaYouNK
Insider selling
Najat Khan sold $84K of Recursion Pharmaceuticals, Inc. (RXRX) stock
Najat Khan, CEO and President of Recursion Pharmaceuticals, Inc. (RXRX), sold 23,588 shares of RXRX stock worth $84K, per an SEC Form 4 filed Jun 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jun 5, 2026.
RXRX has moved +19.8% since the trade date, from $3.31 to $3.97 (Sep 21, 2026 close).
- Traded
- Jun 5, 2026
- Disclosed
- Jun 5, 2026
- Filing delay
- 0 days
- Price since
- +19.8%
- Role
- CEO and President
- Source
- SEC Form 4
More RXRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.